Interleukin-10 (IL-10) 1082 promoter polymorphisms and plasma IL-10 levels in patients with bacterial sepsis

1. HJULER T., POULSEN G., WOHLFAHRT J., KALTOFT M., BIGGAR RJ., MELBYE M. Genetic Susceptibility to Severe Infection in Families with Invasive Pneumococcal Disease. Am J Epidemiol. 2008; 167(7):814–819.10.1093/aje/kwm37618227098Search in Google Scholar

2. WIERSINGA WJ., LEOPOLD SJ., CRANENDONK DR., VAN DER POLL T. Host innate immune responses to sepsis. Virulence. 2014; 5(1):36–44.10.4161/viru.25436391638123774844Search in Google Scholar

3. BOZZA F., SALLUH J., JAPIASSU A., SOARES M., ASSIS E., GOMES R., et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007; 11:R49.10.1186/cc5783220647817448250Search in Google Scholar

4. STANILOVA SA. Functional relevance of IL-10 promoter polymorphisms for sepsis development. Crit Care. 2010; 14(1):119.10.1186/cc8839287551020236506Search in Google Scholar

5. OUYANG L., LV YD., HOU C., WU GB., HE ZH. Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis. Mol Biol Rep. 2013; 40(7): 4327–4332.10.1007/s11033-013-2520-823716201Search in Google Scholar

6. ZENG L., GU W., CHEN K., JIANG D., ZHANG L., DU D., et al. Clinical relevance of the interleukin 10 promoter polymorphisms in Chinese Han patients with major trauma: genetic association studies. Crit Care. 2009, 13:R188.10.1186/cc8182281191719939284Search in Google Scholar

7. STANILOVA SA., MITEVA LD., KARAKOLEV ZT., STEFANOV CS. Interleukin-10-1082 promoter polymorphism in association whith cytokine production and sepsis susceptibility. Intensive Care Med. 2006; 32(2): 260–266.10.1007/s00134-005-0022-416435103Search in Google Scholar

8. SHU Q., FANG X., CHEN Q., STUBER F. IL-10 polymorphism is associated with increased incidence of severe sepsis. Chin Med J (Engl). 2003; 116(11):1756–1759.Search in Google Scholar

9. FAIX JD. Biomarkers of sepsis. Crit Rev Clin Lab Sci. 2013; 50(1): 23–36.10.3109/10408363.2013.764490361396223480440Search in Google Scholar

10. SCHAAF BM., BOEHMKE F., ESNAASHARI H., SEITZER U., KOTHE H., MAASS M., et al. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med. 2003; 168(4): 476–480.10.1164/rccm.200210-1164OC12746253Search in Google Scholar

11. SINGER M., DEUTSCHMAN CS., SEYMOUR C., SHANKAR-HARI M., ANNANE D., BAUER MICHAEL., et al. The Third International Consensus Definitions for Sepsis and Septic Choque (Sepsis-3). JAMA. 2016; 315(8):801–810.10.1001/jama.2016.0287496857426903338Search in Google Scholar

12. SCHULTE W., BERNHAGEN J., BUCALA R. Cytokines in sepsis: potent immunoregulators and potential therapeutic targets – an updated view. Mediators Inflamm. 2013; 2013:165974.10.1155/2013/165974370389523853427Search in Google Scholar

13. PAN W., ZHANG AQ., YUE CL., GAO JW., ZENG L., GU W., et al. Association between interleukin-10 polymorphisms and sepsis: a meta-analysis. Epidemiol Infect. 2015; 143(2): 366–375.10.1017/S095026881400070325497741Search in Google Scholar

14. REINHART K. BAUER M., RIEDEMANN NC., HARTOG CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012; 25(4): 609–634.10.1128/CMR.00016-12348575123034322Search in Google Scholar

15. KANG X., KIM HJ., RAMIREZ M., SALAMEH S., MA X. The septic shock-associated IL-10-1082 A>G polymorphism mediates allele-specific transcription via poly (ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells. J Immunol. 2010; 184(7): 3718–3724.10.4049/jimmunol.0903613363766420181890Search in Google Scholar

16. ABE R., HIRASAWA H., ODA S., SADAHIRO T., NAKAMURA M., WATANABE E., et al., Up-regulation of interleukin-10 mRNA expression in peripheral leukocytes predicts poor outcome and diminished human leukocyte antigen-DR expression on monocytes in septic patients. J Surg Res. 2008; 147(1): 1–8.10.1016/j.jss.2007.07.00917720196Search in Google Scholar

17. SLIGL WI., DRAGAN T., SMITH SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Inf Dis. 2015; 37: 129–134.10.1016/j.ijid.2015.06.02426159847Search in Google Scholar

18. PITTET D, LI N, WOOLSON RF, WENZEL RP. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, populationbased model. Clin Infect Dis 1997; 24: 1068–78.10.1086/5136409195059Search in Google Scholar

19. SLIGL WI., DRAGAN T., SMITH SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Inf Dis. 2015; 37: 129–134.10.1016/j.ijid.2015.06.024Search in Google Scholar

20. STEINHAUSER ML., HOGABOAM CM., KUNKEL SL., LUKACS NW., STRIETER ROBERT M., et al. IL-10 Is a Major Mediator of Sepsis-Induced Impairment in Lung Antibacterial Host Defense. J. Immunol., 1999; 162: 392–399.10.4049/jimmunol.162.1.392Search in Google Scholar

21. ACCARDO PALUMBO A., FORTE GI., PILERI D., VACCARINO L., CONTE F., D’AMELIO L., et al. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. Burns 2012, 38, 208–213.10.1016/j.burns.2011.07.02222079540Search in Google Scholar